Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model
Details
Download: REF.pdf (234.80 [Ko])
State: Public
Version: Final published version
License: Not specified
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
State: Public
Version: Final published version
License: Not specified
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
Serval ID
serval:BIB_D90F2266E49F
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model
Journal
European Journal of Cardio-Thoracic Surgery
ISSN
1010-7940 (Print)
Publication state
Published
Issued date
05/2006
Volume
29
Number
5
Pages
779-83
Notes
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: May
Research Support, Non-U.S. Gov't --- Old month value: May
Abstract
OBJECTIVE: Interleukin-17 (IL-17), a potent proinflammatory cytokine, has been implicated in allograft rejection. We analyzed the efficacy of an adenoviral vector expressing an IL-17 inhibitor in delaying acute allograft rejection in a rat model of heart transplantation, and the biological mechanisms underlying the protective effect. METHODS: We constructed an adenoviral vector expressing a soluble IL-17 receptor-immunoglobulin (IL-17R-Ig) fusion protein. IL-17R-Ig activity was assessed by inhibition of IL-17-induced IL-6 release in HeLa cells preincubated with the vector. Intracoronary vector administration was performed in F344 donor hearts that were placed as vascularized grafts into Lewis hosts. Inflammatory cells infiltrating the graft were analyzed by immunohistology. Cytokine transcripts in the graft were determined by real-time RT-PCR. RESULTS: IL-17R-Ig gene transfer resulted in prolonged allograft survival (16.1+/-3.1 days vs 10.3+/-2.5 days with control virus and 10.1+/-2.1 days with virus dilution buffer alone; p<0.001). IL-17R-Ig gene transfer reduced inflammatory cell infiltrates, especially monocytes/macrophages and CD4+ T cells (p<0.05). It also reduced intragraft cytokine transcripts for interferon-gamma and transforming growth factor-beta (p<0.05) and, to a lesser extent, IL-1beta and tumor necrosis factor-alpha (p=0.083). CONCLUSIONS: Local expression of soluble IL-17 receptor-immunoglobulin attenuates T helper type 1 (Th1) cytokine responses and leukocyte infiltration in rat cardiac allografts, thereby mediating prolonged graft survival. Intragraft IL-17 inhibition may be useful as an adjuvant therapy to systemic immunosuppression in heart transplantation.
Keywords
Adenoviridae/genetics
Animals
CD4-Positive T-Lymphocytes/immunology
Cytokines/biosynthesis/genetics
Gene Therapy/*methods
*Gene Transfer Techniques
Genetic Vectors
Graft Rejection/immunology/*prevention & control
Graft Survival/immunology
*Heart Transplantation
Male
Mice
Mice, Inbred C57BL
Monocytes/immunology
Rats
Rats, Inbred F344
Rats, Inbred Lew
Receptors, Interleukin/genetics/*physiology
Receptors, Interleukin-17
Reverse Transcriptase Polymerase Chain Reaction/methods
Solubility
Pubmed
Web of science
Open Access
Yes
Create date
15/02/2008 12:29
Last modification date
14/02/2022 8:57